Company announcement - No. 4/2017
Zealand Pharma convenes its Annual General Meeting 2017
Copenhagen, March 14, 2017 - Zealand Pharma ("Zealand") convenes the Company's ordinary Annual General Meeting 2017 to be held on
Wednesday April 5, 2017 at 3 pm CET
At the offices of Plesner Law Firm, Amerika Plads 37, 2100 Copenhagen Ø, Denmark
Agenda for the Annual General Meeting 2017
1. Management's report on the Company's activities during the past financial year 2. Approval of the audited Annual Report 2016 3. Resolution on the distribution of profit or the cover of loss in accordance with the approved Annual Report 2016 4. Election of members to the Board of Directors 5. Election of the auditor 6. Authorization for Zealand to acquire treasury shares 7. Proposal by the Board of Directors to update the remuneration policy and overall guidelines for incentive pay 8. Proposal by the Board of Directors to approve the fees for the Board of Directors for the financial year 2017 9. Proposal by the Board of Directors to maintain the Nomination Committee 10. Proposal by the Board of Directors to amend Sections 15.2 and 15.4 of the Company's Articles of Association regarding the Nomination Committee 11. Proposal by the Board of Directors to adopt an updated version of the Rules of Procedure of the Nomination Committee 12. Election of members to the Nomination Committee 13. Proposal by the Board of Directors to disclose information pursuant to the applicable securities legislation, including company announcements, in English only, and amend the Articles of Association accordingly 14. Any other business
The Annual General Meeting will be held in English.
After the Annual General Meeting 2017, refreshments (coffee and cake) will be served, and there will be an opportunity to speak with members of Zealand's Senior Management team.
The notice to convene the Annual General Meeting as well as the registration and proxy forms are available on Zealand's website via the following link: www.zealandpharma.com/annual-general-meeting/
The notice to convene is also enclosed as an appendix to this announcement, and the following should be noted:
Agenda item no. 4: All members of Zealand's Board of Directors elected by the General Meeting are elected on an annual basis. The Nomination Committee proposes the re-election of all the members:
- Rosemary Crane
- Catherine Moukheibir
- Alain Munoz
- Martin Nicklasson
- Michael J. Owen
A profile description for each candidate can be found in Appendix 1 to the enclosed notice to convene.
For further information, please contact:
Britt Meelby Jensen, President and Chief Executive Officer Tel.: +45 51 67 61 28, e-mail: bmj@zealandpharma.com
Mats Blom, Senior Vice President, Chief Financial Officer Tel.: +45 31 53 79 73 , e-mail: mabl@zealandpharma.com
Attachments:
